Equity Overview
Price & Market Data
Price: $5.63
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $68,098,400
Daily Volume: 0
Performance Metrics
1 Week: -4.09%
1 Month: -52.29%
3 Months: -49.87%
6 Months: -53.81%
1 Year: -59.08%
YTD: -51.59%
Company Details
Employees: 150
Sector: Health technology
Industry: Medical specialties
Country: United States
Details
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System. The company offers LENSAR Laser System which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.